About The Author
Dr. Nezami’s Global Impact On Cancer Research
Dr. Nezami, an MD graduate of USC with internships and residencies at UCSF, boasts 23 years of medical practice. He currently serves as the President of Orange Coast Medical Center of Hope in California and is the CEO of Sahel Oncology. Furthermore, his innovative, integrative cancer treatment, patented in over 30 countries, is poised for commercialization. Additionally, with 47 patents globally for cancer consultant and COVID-19, the company offers shares to potential investors through a private placement memorandum.
Moreover, Dr Nezami cancer mission is to revolutionize cancer care by disrupting current standards with natural, non-toxic, yet highly effective therapies. His reputation as an exceptional oncologist in America stems from his pioneering work in integrative oncology.
As a renowned national and international speaker in oncology and epigenetic science, he stands out as the best oncologist. He contributes to numerous research projects, publications, and presentations. Furthermore, co-author of Weil’s “Textbook for (integrative) oncology,” he has investigated best case series for the NIH and NCI and authored “Transition from CRIME to CARE in oncology,” critically reviewing current research.
Additionally, Dr. Nezami’s expertise extends to scientific reviews for peer-reviewed oncology journals and multidisciplinary scientific journals. Moreover, his primary focus lies in customized oncology and epigenetics, where he teaches, consults, and leads research as a Principal Investigator, spearheading multiple clinical trials in advanced and refractory cancer treatment